Cargando…
CL-705G: a novel chemical Kir6.2-specific K(ATP) channel opener
Background: K(ATP) channels have diverse roles, including regulation of insulin secretion and blood flow, and protection against biological stress responses and are excellent therapeutic targets. Different subclasses of K(ATP) channels exist in various tissue types due to the unique assemblies of sp...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319115/ https://www.ncbi.nlm.nih.gov/pubmed/37408765 http://dx.doi.org/10.3389/fphar.2023.1197257 |
_version_ | 1785068176171597824 |
---|---|
author | Gando, Ivan Becerra Flores, Manuel Chen, I.-Shan Yang, Hua-Qian Nakamura, Tomoe Y. Cardozo, Timothy J. Coetzee, William A. |
author_facet | Gando, Ivan Becerra Flores, Manuel Chen, I.-Shan Yang, Hua-Qian Nakamura, Tomoe Y. Cardozo, Timothy J. Coetzee, William A. |
author_sort | Gando, Ivan |
collection | PubMed |
description | Background: K(ATP) channels have diverse roles, including regulation of insulin secretion and blood flow, and protection against biological stress responses and are excellent therapeutic targets. Different subclasses of K(ATP) channels exist in various tissue types due to the unique assemblies of specific pore-forming (Kir6.x) and accessory (SURx) subunits. The majority of pharmacological openers and blockers act by binding to SURx and are poorly selective against the various K(ATP) channel subclasses. Methods and Results: We used 3D models of the Kir6.2/SUR homotetramers based on existing cryo-EM structures of channels in both the open and closed states to identify a potential agonist binding pocket in a functionally critical area of the channel. Computational docking screens of this pocket with the Chembridge Core chemical library of 492,000 drug-like compounds yielded 15 top-ranked “hits”, which were tested for activity against K(ATP) channels using patch clamping and thallium (Tl(+)) flux assays with a Kir6.2/SUR2A HEK-293 stable cell line. Several of the compounds increased Tl(+) fluxes. One of them (CL-705G) opened Kir6.2/SUR2A channels with a similar potency as pinacidil (EC(50) of 9 µM and 11 μM, respectively). Remarkably, compound CL-705G had no or minimal effects on other Kir channels, including Kir6.1/SUR2B, Kir2.1, or Kir3.1/Kir3.4 channels, or Na(+) currents of TE671 medulloblastoma cells. CL-705G activated Kir6.2Δ36 in the presence of SUR2A, but not when expressed by itself. CL-705G activated Kir6.2/SUR2A channels even after PIP(2) depletion. The compound has cardioprotective effects in a cellular model of pharmacological preconditioning. It also partially rescued activity of the gating-defective Kir6.2-R301C mutant that is associated with congenital hyperinsulinism. Conclusion: CL-705G is a new Kir6.2 opener with little cross-reactivity with other channels tested, including the structurally similar Kir6.1. This, to our knowledge, is the first Kir-specific channel opener. |
format | Online Article Text |
id | pubmed-10319115 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103191152023-07-05 CL-705G: a novel chemical Kir6.2-specific K(ATP) channel opener Gando, Ivan Becerra Flores, Manuel Chen, I.-Shan Yang, Hua-Qian Nakamura, Tomoe Y. Cardozo, Timothy J. Coetzee, William A. Front Pharmacol Pharmacology Background: K(ATP) channels have diverse roles, including regulation of insulin secretion and blood flow, and protection against biological stress responses and are excellent therapeutic targets. Different subclasses of K(ATP) channels exist in various tissue types due to the unique assemblies of specific pore-forming (Kir6.x) and accessory (SURx) subunits. The majority of pharmacological openers and blockers act by binding to SURx and are poorly selective against the various K(ATP) channel subclasses. Methods and Results: We used 3D models of the Kir6.2/SUR homotetramers based on existing cryo-EM structures of channels in both the open and closed states to identify a potential agonist binding pocket in a functionally critical area of the channel. Computational docking screens of this pocket with the Chembridge Core chemical library of 492,000 drug-like compounds yielded 15 top-ranked “hits”, which were tested for activity against K(ATP) channels using patch clamping and thallium (Tl(+)) flux assays with a Kir6.2/SUR2A HEK-293 stable cell line. Several of the compounds increased Tl(+) fluxes. One of them (CL-705G) opened Kir6.2/SUR2A channels with a similar potency as pinacidil (EC(50) of 9 µM and 11 μM, respectively). Remarkably, compound CL-705G had no or minimal effects on other Kir channels, including Kir6.1/SUR2B, Kir2.1, or Kir3.1/Kir3.4 channels, or Na(+) currents of TE671 medulloblastoma cells. CL-705G activated Kir6.2Δ36 in the presence of SUR2A, but not when expressed by itself. CL-705G activated Kir6.2/SUR2A channels even after PIP(2) depletion. The compound has cardioprotective effects in a cellular model of pharmacological preconditioning. It also partially rescued activity of the gating-defective Kir6.2-R301C mutant that is associated with congenital hyperinsulinism. Conclusion: CL-705G is a new Kir6.2 opener with little cross-reactivity with other channels tested, including the structurally similar Kir6.1. This, to our knowledge, is the first Kir-specific channel opener. Frontiers Media S.A. 2023-06-20 /pmc/articles/PMC10319115/ /pubmed/37408765 http://dx.doi.org/10.3389/fphar.2023.1197257 Text en Copyright © 2023 Gando, Becerra Flores, Chen, Yang, Nakamura, Cardozo and Coetzee. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Gando, Ivan Becerra Flores, Manuel Chen, I.-Shan Yang, Hua-Qian Nakamura, Tomoe Y. Cardozo, Timothy J. Coetzee, William A. CL-705G: a novel chemical Kir6.2-specific K(ATP) channel opener |
title | CL-705G: a novel chemical Kir6.2-specific K(ATP) channel opener |
title_full | CL-705G: a novel chemical Kir6.2-specific K(ATP) channel opener |
title_fullStr | CL-705G: a novel chemical Kir6.2-specific K(ATP) channel opener |
title_full_unstemmed | CL-705G: a novel chemical Kir6.2-specific K(ATP) channel opener |
title_short | CL-705G: a novel chemical Kir6.2-specific K(ATP) channel opener |
title_sort | cl-705g: a novel chemical kir6.2-specific k(atp) channel opener |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319115/ https://www.ncbi.nlm.nih.gov/pubmed/37408765 http://dx.doi.org/10.3389/fphar.2023.1197257 |
work_keys_str_mv | AT gandoivan cl705ganovelchemicalkir62specifickatpchannelopener AT becerrafloresmanuel cl705ganovelchemicalkir62specifickatpchannelopener AT chenishan cl705ganovelchemicalkir62specifickatpchannelopener AT yanghuaqian cl705ganovelchemicalkir62specifickatpchannelopener AT nakamuratomoey cl705ganovelchemicalkir62specifickatpchannelopener AT cardozotimothyj cl705ganovelchemicalkir62specifickatpchannelopener AT coetzeewilliama cl705ganovelchemicalkir62specifickatpchannelopener |